General Announcement::Bond Repurchase

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
07-Apr-2022 22:59:47
Status
New
Announcement Sub Title
Bond Repurchase
Announcement Reference
SG220407OTHR6E1B
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
07/04/2022 00:00:00
Description (Please provide a detailed description of the event in the box below)
REPURCHASE OF USD 200,000,000 2 PER CENT. RESETTABLE ONWARD STARTING EQUITY LINKED SECURITIES DUE 2022

Attachments

SGX Annnouncement_07042022.pdf
Total size =78K